Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT2032220573
JPRN-jRCT2032220573
Completed
未知

Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillation

Tamura Yuichi0 sites45 target enrollmentJanuary 17, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsparoxysmal atrial fibrillationAtrial FibrillationD001281

Overview

Phase
未知
Intervention
Not specified
Conditions
paroxysmal atrial fibrillation
Sponsor
Tamura Yuichi
Enrollment
45
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 17, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tamura Yuichi

Eligibility Criteria

Inclusion Criteria

  • •Paroxysmal atrial fibrillation group
  • •1\.Persons who have given written consent
  • •2\.Persons diagnosed as paroxysmal atrial fibrillation
  • •3\.Persons expected to have an atrial fibrillation attack more frequency than once a week
  • •Control group
  • •1\.Persons with confirmed sinus rhythm

Exclusion Criteria

  • •Paroxysmal atrial fibrillation group
  • •1\.Persons diagnosed with persistent or permanent atrial fibrillation
  • •2\.Persons undergoing treatment(catheter ablation, open heart surgery, pacemaker implantation, percutaneous atrial septal defect closure)
  • •Control group
  • •1\.Persons who have a history of diagnosis of paroxysmal atrial fibrillation, persistent atrial fibrillation, or permanent atrial fibrillation
  • •2\.Persons undergoing treatment(catheter ablation, open heart surgery, pacemaker implantation, percutaneous atrial septal defect closure)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillatioparoxysmal atrial fibrillation
JPRN-UMIN000047182IUHW45
Active, not recruiting
Phase 1
Validation of a test system for development of medications for alcoholism
EUCTR2015-002831-16-DETechnische Universität Dresden
Not yet recruiting
Not Applicable
A performance evaluation study for the testing of DNA extracted from either tumor tissue biopsy samples or plasma, using the therascreen® EGFR Plus RGQ PCR Kit, from subjects with Non-Small Cell Lung Cancer, being screened for inclusion in Taiho Oncology, Inc*s Clinical Trial (Protocol No. 10073010).Lung CancerNon Small Cell Lung Cancer10038666
NL-OMON56744QIAGE15
Recruiting
Not Applicable
A study to determine the ability of a blood test for B-type Natriuretic Peptide signal peptide (BNP-SP) to act as an early indicator in Acute Coronary Syndrome (ACS)).
ACTRN12609000057280Health Research Council of New Zealand2,000
Recruiting
Not Applicable
Testing of a new test system for diagnosis and therapy planning of severe blistering autoimmune diseases of the skiL10.0L12.0Pemphigus vulgarisBullous pemphigoid
DRKS00027499niversitätsklinikum der RWTH Aachen40